Latest Biotech News

Regencell Bioscience Holdings (NASDAQ: RGC) experienced an extraordinary stock price increase exceeding 64,000% during a speculative frenzy in mid-2025. The Hong Kong-based biotech focuses on...

Researchers demonstrated chip-fiber-chip quantum teleportation within a star-topology quantum network, advancing the development of scalable quantum communication infrastructure. This breakthrough...

Researchers have developed a novel physics-based algorithm that leverages artificial intelligence to design biomolecules with tailor-made properties. This development marks a significant advance...

Emerging biologics called T cell engagers are poised to transform autoimmune disease treatment by enabling an 'immune reset.' Unlike conventional broad immunosuppression, these agents directly...

The FDA has initiated a pilot program to accelerate regulatory reviews of generic drugs that are tested and manufactured entirely in the United States using domestically sourced active...

Trogenix Biosciences has closed a $95 million Series A financing round to propel its novel brain cancer treatment technology toward clinical evaluation. The company's lead program leverages a...

Pfizer saw its shares jump 14% over two trading days following its agreement with the Trump administration granting a three-year tariff exemption in exchange for increased U.S. drug manufacturing...

Regencell Bioscience Holdings experienced an unprecedented stock price surge of 64,000% within a week, fueled by retail mania and a 38-for-1 stock split that dramatically increased liquidity....

Researchers have unveiled EDG-PPIS, an innovative equivariant and dual-scale graph neural network framework, significantly enhancing prediction accuracy of protein-protein interaction sites. This...

At the European Association of Nuclear Medicine Congress, researchers revealed that metabolically active visceral fat contributes to more aggressive endometrial cancer phenotypes. This finding...

Recent comprehensive mapping highlights the global clinical advancement of Natural Killer (NK) cell therapies in treating solid tumors. These immunotherapies, designed to harness innate immune...

The newly developed DeepMice model represents a revolutionary computational approach to protein-ligand molecular docking, employing advanced multilevel mapping techniques. This novel framework...

Pfizer struck a landmark deal with the U.S. government granting it a three-year tariff exemption in exchange for commitments to enhance domestic drug manufacturing and implement "most favored...

Trogenix reported a $95 million Series A funding round aimed at bolstering its novel 'Trojan horse' therapeutic platform targeting glioblastoma, a highly aggressive form of brain cancer. This...

New research published in Nature Computational Science introduces virtual brain twins—advanced computational models replicating patient-specific neurophysiology—to precisely simulate epileptic...

Hong Kong-based biotech Regencell Bioscience Holdings experienced an extraordinary stock surge exceeding 64,000% during mid-2025 driven by retail speculation, social media hype, and a 38-for-1...

The U.S. Food and Drug Administration has initiated a pilot program aimed at expediting the regulatory review of generic drugs that are tested, manufactured, and sourced entirely within the United...

A comprehensive landscape analysis reveals a growing global pipeline of Natural Killer (NK) cell therapies for solid tumors, underscoring their emerging role in immuno-oncology. These therapies...

Dovetail Genomics' innovative LinkPrep technology enables simultaneous sequencing of DNA bases and three-dimensional genome organization, uncovering structural variants and regulatory disruptions...

New findings indicate that targeting Polo-like kinase 1 (PLK1) potentiates gemcitabine-induced apoptosis in pancreatic cancer cells, providing a synergistic therapeutic strategy. This study...